Related Experiment Video
Updated: Jul 16, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Erectile vascular dysfunction and analysis of the risk factors related to it: clinical experience
S La Vignera1, A E Calogero, M A Cannizzaro
1Unit of Endocrinology, Andrology and Internal Medicine, Department of Biomedical Sciences, Garibaldi Hospital, University of Catania, Catania, Italy. sandrolavignera@email.it
Aim:
Preliminarily we analyzed the rate incidence of organic and psychological causes of erectile dysfunction in large cohort of patients observed during last year. Particularly we wanted to analyze the factors of risk correlated to the vascular erectile dysfunction.
Methods:
The epidemiological study has been conducted on a cohort of 101 patients (age 25-75 years) suffering from erectile dysfunction since 1-10 years (average: 2.6 years) and administrated during the last year by the Institute of Andrology at the University of Catania.
Results:
The organic erectile dysfunction had a frequency more elevated in comparison to the psychological erectile dysfunction, respectively engraving in 54.5% and in 45.5%. Between the organic causes of erectile dysfunction, the vascular arterial forms of erectile dysfunction represented highest rates (32.7% of the patients). The group of patients affected by vascular arterial erectile dysfunction showed several factors of risk, present in all the patients in single or combined way (comorbidity). The rate of such factors was >30% for 4 examined factors: hypertension (57.5%), smoke (45.4%), diabetes mellitus (39.3%), hyperlipidaemia (33.3%).
Conclusions:
The erectile dysfunction is frequently associated to organic causes, prevalently of arterial vascular nature. The correction of the factors of risk could lead to a better control of the erectile dysfunction and reduce the extension of the vascular arterial damage to other districts.
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Hypertension III: Clinical Manifestations and Diagnostic Studies
Vascular Resistance
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests